FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005265770> ?p ?o ?g. }

• W2005265770 endingPage "1142" @default.
• W2005265770 startingPage "1134" @default.
• W2005265770 abstract "In recent years, successful examples of antisense oligonucleotide (AS) therapy for genetic diseases have stimulated scientists to investigate its application on cancer diseases. AS can be used to down-regulate the mRNA and protein expression by annealing to specific region of the target mRNA which is responsible for the malignancy. Glucose transporter 5 (Glut5) is a tissue specific transporter that can be found on breast cancer tissues but not on normal breast tissues. Therefore, it is of clinical interest to investigate whether AS against Glut5 mRNA can tackle breast cancer. In this study, two cell lines, MCF-7 which is estrogen-receptor positive and MDA-MB-231 which is estrogen-receptor negative, were used to mimic breast cancer tissues at early and late stages, respectively. A 15-base sequence around the start codon of Glut5 was used. It was found that AS against Glut5 exerted anti-proliferative effect on both of these two breast tumor cell lines and seemed to exert its effect via the suppression of expression of Glut5 proteins in the cells. AS against Glut5 exhibited no effect on human hepatoma HepG2 cells which do not possess any Glut5. The results imply an alternative way in treating breast tumor as the AS against Glut5, unlike tamoxifen, takes effect on breast tumor cells via suppressing the expression of Glut5 that they specifically possess, and regardless whether the breast tumors are estrogen dependent or not." @default.
• W2005265770 created "2016-06-24" @default.
• W2005265770 creator A5012697645 @default.
• W2005265770 creator A5023020840 @default.
• W2005265770 creator A5041465938 @default.
• W2005265770 creator A5080857189 @default.
• W2005265770 date "2004-09-24" @default.
• W2005265770 modified "2023-10-09" @default.
• W2005265770 title "Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5" @default.
• W2005265770 cites W108983102 @default.
• W2005265770 cites W1492842792 @default.
• W2005265770 cites W1524240684 @default.
• W2005265770 cites W1970629182 @default.
• W2005265770 cites W1976506650 @default.
• W2005265770 cites W1982477267 @default.
• W2005265770 cites W1985301073 @default.
• W2005265770 cites W2008307864 @default.
• W2005265770 cites W2019708716 @default.
• W2005265770 cites W2026035143 @default.
• W2005265770 cites W2064558158 @default.
• W2005265770 cites W2064689428 @default.
• W2005265770 cites W2090956406 @default.
• W2005265770 cites W2097687227 @default.
• W2005265770 cites W2109990295 @default.
• W2005265770 cites W2135514341 @default.
• W2005265770 cites W2294840248 @default.
• W2005265770 cites W4236425814 @default.
• W2005265770 doi "https://doi.org/10.1002/jcb.20270" @default.
• W2005265770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15449313" @default.
• W2005265770 hasPublicationYear "2004" @default.
• W2005265770 type Work @default.
• W2005265770 sameAs 2005265770 @default.
• W2005265770 citedByCount "47" @default.
• W2005265770 countsByYear W20052657702012 @default.
• W2005265770 countsByYear W20052657702013 @default.
• W2005265770 countsByYear W20052657702015 @default.
• W2005265770 countsByYear W20052657702016 @default.
• W2005265770 countsByYear W20052657702017 @default.
• W2005265770 countsByYear W20052657702018 @default.
• W2005265770 countsByYear W20052657702019 @default.
• W2005265770 countsByYear W20052657702020 @default.
• W2005265770 countsByYear W20052657702021 @default.
• W2005265770 countsByYear W20052657702022 @default.
• W2005265770 countsByYear W20052657702023 @default.
• W2005265770 crossrefType "journal-article" @default.
• W2005265770 hasAuthorship W2005265770A5012697645 @default.
• W2005265770 hasAuthorship W2005265770A5023020840 @default.
• W2005265770 hasAuthorship W2005265770A5041465938 @default.
• W2005265770 hasAuthorship W2005265770A5080857189 @default.
• W2005265770 hasConcept C109541995 @default.
• W2005265770 hasConcept C121608353 @default.
• W2005265770 hasConcept C126322002 @default.
• W2005265770 hasConcept C134018914 @default.
• W2005265770 hasConcept C1491633281 @default.
• W2005265770 hasConcept C161573976 @default.
• W2005265770 hasConcept C2777164284 @default.
• W2005265770 hasConcept C2777176818 @default.
• W2005265770 hasConcept C2779306644 @default.
• W2005265770 hasConcept C2994423619 @default.
• W2005265770 hasConcept C502942594 @default.
• W2005265770 hasConcept C530470458 @default.
• W2005265770 hasConcept C54355233 @default.
• W2005265770 hasConcept C55493867 @default.
• W2005265770 hasConcept C62112901 @default.
• W2005265770 hasConcept C71924100 @default.
• W2005265770 hasConcept C84606932 @default.
• W2005265770 hasConcept C86803240 @default.
• W2005265770 hasConceptScore W2005265770C109541995 @default.
• W2005265770 hasConceptScore W2005265770C121608353 @default.
• W2005265770 hasConceptScore W2005265770C126322002 @default.
• W2005265770 hasConceptScore W2005265770C134018914 @default.
• W2005265770 hasConceptScore W2005265770C1491633281 @default.
• W2005265770 hasConceptScore W2005265770C161573976 @default.
• W2005265770 hasConceptScore W2005265770C2777164284 @default.
• W2005265770 hasConceptScore W2005265770C2777176818 @default.
• W2005265770 hasConceptScore W2005265770C2779306644 @default.
• W2005265770 hasConceptScore W2005265770C2994423619 @default.
• W2005265770 hasConceptScore W2005265770C502942594 @default.
• W2005265770 hasConceptScore W2005265770C530470458 @default.
• W2005265770 hasConceptScore W2005265770C54355233 @default.
• W2005265770 hasConceptScore W2005265770C55493867 @default.
• W2005265770 hasConceptScore W2005265770C62112901 @default.
• W2005265770 hasConceptScore W2005265770C71924100 @default.
• W2005265770 hasConceptScore W2005265770C84606932 @default.
• W2005265770 hasConceptScore W2005265770C86803240 @default.
• W2005265770 hasIssue "6" @default.
• W2005265770 hasLocation W20052657701 @default.
• W2005265770 hasLocation W20052657702 @default.
• W2005265770 hasOpenAccess W2005265770 @default.
• W2005265770 hasPrimaryLocation W20052657701 @default.
• W2005265770 hasRelatedWork W1982850748 @default.
• W2005265770 hasRelatedWork W200925908 @default.
• W2005265770 hasRelatedWork W2034033931 @default.
• W2005265770 hasRelatedWork W2087504465 @default.
• W2005265770 hasRelatedWork W2117019370 @default.
• W2005265770 hasRelatedWork W2335928397 @default.
• W2005265770 hasRelatedWork W2364285896 @default.
• W2005265770 hasRelatedWork W3010551324 @default.

• next